Basic Information
AnaCardio is a clinical-stage biopharmaceutical company developing new drugs for the treatment of heart failure, a potentially fatal condition and the most common reason for hospitalization.
AnaCardio AB
Stockholm,Stockholm,Sweden
less than 15 people
January 01, 2017
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios